Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
NCT07013201· Phase 2· LEO Pharma· Source
Contact: Clinical Disclosure
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error